Who Buys Leflunomide from India — 202 Importers Behind a $14.9M Market
India's leflunomide import market is served by 202 active buyers who collectively imported $14.9M across 816 shipments. EVERSANA LIFE SCIENCE SERVICES (UNITED STATES) leads with a 35.0% market share, followed by JDS CO LTD and ROPACK. The top 5 buyers together control 48.8% of total import value, reflecting a moderately competitive buyer landscape.
Top Leflunomide Importers — Ranked by Import Value
EVERSANA LIFE SCIENCE SERVICES (UNITED STATES) is the leading leflunomide importer from India, holding a 35.0% share of the $14.9M market across 816 shipments from 202 buyers. The top 5 buyers — EVERSANA LIFE SCIENCE SERVICES (UNITED STATES), JDS CO LTD (MYANMAR), ROPACK (CANADA), NATIONS TRUST BANK PLC. (SRI LANKA), EMCURE PHARMA CHILE S.P.A. (CHILE) — collectively control 48.8% of total import value.
Top Leflunomide Buyers & Importers
Ranked by import value · 202 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | EVERSANA LIFE SCIENCE SERVICESUNITED STATES LEFLUNOMIDE TABS USP 20MG 1X30 PACKS)LEFLUNOMIDE TAB 20MG X 30'S USLEFLUNOMIDE TABLETS USP 20MG [62640 PACK | $5.2M | 5 | 35.0% |
| 2 | JDS CO LTDMYANMAR LEFRA 20 TABLET LEFLUNOMIDE 20MG NOS=1X5X10 TABOTHERS : LEFRA 20 TABLET - PACK SIZE 1X5X10 TABSLEFRA 20 TABLET | $709.8K | 5 | 4.8% |
| 3 | ROPACKCANADA LEFLUNOMIDE TABLET 20MGLEFLUNOMIDE TABLET 20MG [PAC SIZE:1X4000 | $511.9K | 5 | 3.4% |
| 4 | NATIONS TRUST BANK PLC.SRI LANKA LEFRA 10 TABLET(LEFLUNLEFRA 10 TABLET | $457.9K | 5 | 3.1% |
| 5 | EMCURE PHARMA CHILE S.P.A.CHILE PHARMACEUTICALS PRODUCTS: SOLIVO 20 MG TABLET 6X10PHARMACEUTICAL PRODUCTS :- SOLIVO 20 MG TABLET 6X10 | $373.7K | 5 | 2.5% |
| 6 | JDS CO, LTD,MYANMAR LEFRA 20 TABLET LEFLUNOMIDE 20MG NOS=1X5X10 TABOTHERS : LEFRA 20 TABLET - PACK SIZE 1X5X10 TABSLEFRA 20 TABLET | $372.4K | 5 | 2.5% |
| 7 | JDS CO. LIMITEDMYANMAR LEFRA 20 TABLET LEFLUNOMIDE 20MG NOS=1X5X10 TABOTHERS : LEFRA 20 TABLET - PACK SIZE 1X5X10 TABSLEFRA 20 TABLET | $326.0K | 5 | 2.2% |
| 8 | STADAPHARM GMBHGERMANY LEFLUNOMIDE 20 MG TABLETS 10X10'S_DELEFLUNOMIDE 20 MG TABLETS 10X10'S DELEFLUNOMIDE 20 MG TABLETS 10X10 S DE | $320.8K | 5 | 2.2% |
| 9 | HATTON NATIONAL BANK PLCSRI LANKA LEFRA 10 TABLET(LEFLUNLEFRA 10 TABLET | $293.1K | 5 | 2.0% |
| 10 | LLP "DARI-PHARM (KAZAKHSTAN)KAZAKHSTAN LEFNO-20 TABLETS 3X10S LEFLUNOMIDE 20MLEFNO-20 TABLETS 3X10SLEFNO-20 TABLETS 3X10S B/N.1005581 DOM 12.2024 DOE 11.2027 | $269.0K | 5 | 1.8% |
| 11 | ALLOGA (NEDERLAND) B.VNETHERLANDS LEFLUNOMIDE 20 MG TABLETS 10X10'S_DELEFLUNOMIDE 20 MG TABLETS 10X10'S DELEFLUNOMIDE 20 MG TABLETS 10X10 S DE | $260.0K | 5 | 1.7% |
| 12 | EMCURE PHARMA CHILE S P ACHILE PHARMACEUTICALS PRODUCTS: SOLIVO 20 MG TABLET 6X10PHARMACEUTICAL PRODUCTS :- SOLIVO 20 MG TABLET 6X10 | $253.0K | 5 | 1.7% |
| 13 | TILLOMED LABORATORIES LTDUNITED KINGDOM PHARMACEUTICAL PRODUCTS - LEFLUNOMIDE 10MG TABLETSPHARMACEUTICAL PRODUCTS-LEFLUNOMIDE 10MGLEFLUNOMIDE 20MG TABLETS- 3 X 10 TAB (EA | $252.4K | 5 | 1.7% |
| 14 | GLADPHARM LTD.UKRAINE LEFNO-20 TABLETS 3X10S(LEFLUNOMIDE 20MGLEFNO-20 TABLETS 3X10SBNO1003215,DOM01.2024,DOE12.2026 | $225.5K | 5 | 1.5% |
| 15 | TILLOMED LABORATORIES LTD.UNITED KINGDOM PHARMACEUTICAL PRODUCTS - LEFLUNOMIDE 10MG TABLETSPHARMACEUTICAL PRODUCTS-LEFLUNOMIDE 10MGLEFLUNOMIDE 20MG TABLETS- 3 X 10 TAB (EA | $214.1K | 5 | 1.4% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Leflunomide — and from which countries?
Flow of Leflunomide exports from India: each country's share and the named importers behind the numbers
Leflunomide — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1United States
United States emerges as the first largest importing country, achieving a total trade value of $6.0M through 97 shipments. This represents a market share of 40.5% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United States has a diverse importer base, with their top importers including:
• EVERSANA LIFE SCIENCE SERVICES - $5.2M (86.6% of country's total business)
• XXPINXXHARXXCEUXXCALXXINCX - $173.5K (2.9% of country's total business)
• LUPIN PHARMACEUTICALS INC - $173.1K (2.9% of country's total business)
Key Insight: United States demonstrates strong market positioning with an average shipment value of $62.0K, indicating premium pricing strategy compared to the market average of $18.2K.
United States is a key market for Leflunomide imports, representing 40.5% of total trade value.
2Myanmar
Myanmar emerges as the second largest importing country, achieving a total trade value of $2.1M through 12 shipments. This represents a market share of 14.2% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Myanmar has a diverse importer base, with their top importers including:
• JDS CO LTD - $709.8K (33.7% of country's total business)
• JDS CO, LTD, - $372.4K (17.7% of country's total business)
• JDS CO. LIMITED - $326.0K (15.5% of country's total business)
• JDS CO., LTD.. - $178.5K (8.5% of country's total business)
Key Insight: Myanmar demonstrates strong market positioning with an average shipment value of $175.5K, indicating premium pricing strategy compared to the market average of $18.2K.
Myanmar is a key market for Leflunomide imports, representing 14.2% of total trade value.
3Sri Lanka
Sri Lanka emerges as the third largest importing country, achieving a total trade value of $1.2M through 15 shipments. This represents a market share of 8.4% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Sri Lanka has a diverse importer base, with their top importers including:
• NATIONS TRUST BANK PLC. - $457.9K (36.7% of country's total business)
• HATTON NATIONAL BANK PLC - $293.1K (23.5% of country's total business)
Key Insight: Sri Lanka demonstrates strong market positioning with an average shipment value of $83.1K, indicating premium pricing strategy compared to the market average of $18.2K.
Sri Lanka is a key market for Leflunomide imports, representing 8.4% of total trade value.
4United Kingdom
United Kingdom emerges as the fourth largest importing country, achieving a total trade value of $778.0K through 48 shipments. This represents a market share of 5.2% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United Kingdom has a diverse importer base, with their top importers including:
• TILLOMED LABORATORIES LTD - $252.4K (32.4% of country's total business)
• TILLOMED LABORATORIES LTD. - $214.1K (27.5% of country's total business)
Key Insight: United Kingdom demonstrates strong market positioning with an average shipment value of $16.2K, indicating competitive pricing strategy compared to the market average of $18.2K.
United Kingdom is a key market for Leflunomide imports, representing 5.2% of total trade value.
5Chile
Chile emerges as the fifth largest importing country, achieving a total trade value of $732.8K through 27 shipments. This represents a market share of 4.9% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Chile has a diverse importer base, with their top importers including:
• EMCURE PHARMA CHILE S.P.A. - $373.7K (51.0% of country's total business)
• EMCURE PHARMA CHILE S P A - $253.0K (34.5% of country's total business)
Key Insight: Chile demonstrates strong market positioning with an average shipment value of $27.1K, indicating premium pricing strategy compared to the market average of $18.2K.
Chile is a key market for Leflunomide imports, representing 4.9% of total trade value.
Buyer Segment Analysis
TransData Nexus Leflunomide buyer market intelligence
1Buyer Segment Analysis
Our data indicates that Leflunomide exports from India amounted to $14.9 million across 816 shipments, involving 106 exporters and 202 buyers across 63 importing countries. The repeat buyer rate stands at 53.0%, suggesting a stable demand among established purchasers.
Distributors: Entities such as EVERSANA LIFE SCIENCE SERVICES (United States, $5.21M) and STADAPHARM GMBH (Germany, $0.32M) fall into this category. Distributors typically procure large volumes to supply various healthcare providers, including hospitals and pharmacies. Their purchasing patterns are characterized by bulk orders and long-term contracts to ensure consistent supply chains.
Contract Manufacturers: Companies like ROPACK (Canada, $0.51M) are identified as contract manufacturers. These organizations import active pharmaceutical ingredients (APIs) like Leflunomide to produce finished dosage forms for other pharmaceutical companies. Their procurement is project-based, aligning with production schedules and client demands.
Re-exporters: Entities such as JDS CO LTD (Myanmar, $0.71M) and JDS CO. LIMITED (Myanmar, $0.33M) serve as re-exporters. They import Leflunomide for redistribution to neighboring regions, leveraging strategic geographic positions. Their buying behavior includes moderate-sized orders with a focus on market demand fluctuations.
Government Procurement: Institutions like NATIONS TRUST BANK PLC. (Sri Lanka, $0.46M) and HATTON NATIONAL BANK PLC (Sri Lanka, $0.29M) are involved in government procurement. These entities facilitate national tenders to supply public healthcare systems. Their purchasing patterns are influenced by government budgets, policy decisions, and public health needs, often resulting in large, periodic orders.
Country-Specific Import Regulations
TransData Nexus Leflunomide buyer market intelligence
1Country-Specific Import Regulations
- 1Regulatory Authority: U.S. Food and Drug Administration (FDA).
- 2Import Registration Process: Importers must ensure that Leflunomide is FDA-approved. The process involves submitting a New Drug Application (NDA) or an Abbreviated New Drug Application (ANDA) for generic versions.
- 3Estimated Timeline: The approval process can range from 10 months to several years, depending on the application type and completeness.
- 4Import Tariff/Duty: Pharmaceutical products under HS Code 30049099 are generally duty-free, but importers should verify current tariffs with U.S. Customs and Border Protection.
United States:
- 1Regulatory Authority: Food and Drug Administration, Ministry of Health and Sports.
- 2Import Registration Process: Importers must obtain a Drug Importation Certificate by submitting product dossiers, including manufacturing and quality control details.
- 3Estimated Timeline: The registration process typically takes 6 to 12 months.
- 4Import Tariff/Duty: Pharmaceuticals are subject to import duties; specific rates should be confirmed with Myanmar Customs.
Myanmar:
- 1Regulatory Authority: National Medicines Regulatory Authority (NMRA).
- 2Import Registration Process: Importers must register the product with NMRA, providing comprehensive documentation on safety, efficacy, and quality.
- 3Estimated Timeline: The registration process can take approximately 6 to 9 months.
- 4Import Tariff/Duty: Pharmaceuticals may be subject to import duties; current rates should be verified with Sri Lanka Customs.
Sri Lanka:
- 1Regulatory Authority: Medicines and Healthcare products Regulatory Agency (MHRA).
- 2Import Registration Process: Importers must hold a Wholesale Dealer's License and ensure the product has a Marketing Authorization.
- 3Estimated Timeline: The approval process can take 12 to 18 months.
- 4Import Tariff/Duty: Pharmaceuticals under HS Code 30049099 are generally duty-free; importers should confirm with UK Customs.
United Kingdom:
- 1Regulatory Authority: Instituto de Salud Pública de Chile (ISP).
- 2Import Registration Process: Importers must register the product with ISP, submitting detailed dossiers on quality, safety, and efficacy.
- 3Estimated Timeline: The registration process typically takes 12 to 24 months.
- 4Import Tariff/Duty: Pharmaceuticals may be subject to import duties; specific rates should be confirmed with Chilean Customs.
Chile:
Demand Drivers & Market Opportunity
TransData Nexus Leflunomide buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Leflunomide is primarily driven by the prevalence of autoimmune diseases such as rheumatoid arthritis. According to the World Health Organization (WHO), rheumatoid arthritis affects approximately 0.3–1% of the global population, with higher prevalence in developed countries. This underscores a consistent need for disease-modifying antirheumatic drugs (DMARDs) like Leflunomide.
Government healthcare programs and the expansion of universal health coverage significantly influence Leflunomide procurement. Many countries have incorporated Leflunomide into their national essential medicines lists, aligning with WHO recommendations to ensure accessibility to critical treatments. Additionally, international organizations such as the WHO and the Global Fund often facilitate tender-based purchasing, enhancing the availability of essential medicines in low- and middle-income countries. Our data, indicating 202 buyers across 63 countries, reflects a broad and sustained market opportunity for Leflunomide.
Common Questions — Leflunomide Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest leflunomide buyer importing from India?
Based on import volume and value, EVERSANA LIFE SCIENCE SERVICES (UNITED STATES) leads with $5.2M in imports and a 35.0% market share — the highest of any single leflunomide importer. JDS CO LTD (MYANMAR) and ROPACK (CANADA) are the next largest buyers.
QHow many companies buy leflunomide from India?
There are 202 active leflunomide buyers importing from India, with a combined market of $14.9M across 816 shipments to 63 countries. The top 5 buyers hold 48.8% of total import value, while the remaining 197 buyers handle the other 51.2%.
QWhich countries import the most leflunomide from India?
The top importing countries for leflunomide from India are United States (40.5%), Myanmar (14.2%), Sri Lanka (8.4%), United Kingdom (5.2%), Chile (4.9%). These markets represent the largest demand centres for Indian pharmaceutical exports of leflunomide, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for leflunomide from India?
The average import transaction value for leflunomide from India is $18.2K, with an average unit price of $6.98 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Leflunomide buyer market intelligence
1Buyer Segment Analysis
Our data indicates that Leflunomide exports from India amounted to $14.9 million across 816 shipments, involving 106 exporters and 202 buyers across 63 importing countries. The repeat buyer rate stands at 53.0%, suggesting a stable demand among established purchasers.
Distributors: Entities such as EVERSANA LIFE SCIENCE SERVICES (United States, $5.21M) and STADAPHARM GMBH (Germany, $0.32M) fall into this category. Distributors typically procure large volumes to supply various healthcare providers, including hospitals and pharmacies. Their purchasing patterns are characterized by bulk orders and long-term contracts to ensure consistent supply chains.
Contract Manufacturers: Companies like ROPACK (Canada, $0.51M) are identified as contract manufacturers. These organizations import active pharmaceutical ingredients (APIs) like Leflunomide to produce finished dosage forms for other pharmaceutical companies. Their procurement is project-based, aligning with production schedules and client demands.
Re-exporters: Entities such as JDS CO LTD (Myanmar, $0.71M) and JDS CO. LIMITED (Myanmar, $0.33M) serve as re-exporters. They import Leflunomide for redistribution to neighboring regions, leveraging strategic geographic positions. Their buying behavior includes moderate-sized orders with a focus on market demand fluctuations.
Government Procurement: Institutions like NATIONS TRUST BANK PLC. (Sri Lanka, $0.46M) and HATTON NATIONAL BANK PLC (Sri Lanka, $0.29M) are involved in government procurement. These entities facilitate national tenders to supply public healthcare systems. Their purchasing patterns are influenced by government budgets, policy decisions, and public health needs, often resulting in large, periodic orders.
Country-Specific Import Regulations
TransData Nexus Leflunomide buyer market intelligence
1Country-Specific Import Regulations
- 1Regulatory Authority: U.S. Food and Drug Administration (FDA).
- 2Import Registration Process: Importers must ensure that Leflunomide is FDA-approved. The process involves submitting a New Drug Application (NDA) or an Abbreviated New Drug Application (ANDA) for generic versions.
- 3Estimated Timeline: The approval process can range from 10 months to several years, depending on the application type and completeness.
- 4Import Tariff/Duty: Pharmaceutical products under HS Code 30049099 are generally duty-free, but importers should verify current tariffs with U.S. Customs and Border Protection.
United States:
- 1Regulatory Authority: Food and Drug Administration, Ministry of Health and Sports.
- 2Import Registration Process: Importers must obtain a Drug Importation Certificate by submitting product dossiers, including manufacturing and quality control details.
- 3Estimated Timeline: The registration process typically takes 6 to 12 months.
- 4Import Tariff/Duty: Pharmaceuticals are subject to import duties; specific rates should be confirmed with Myanmar Customs.
Myanmar:
- 1Regulatory Authority: National Medicines Regulatory Authority (NMRA).
- 2Import Registration Process: Importers must register the product with NMRA, providing comprehensive documentation on safety, efficacy, and quality.
- 3Estimated Timeline: The registration process can take approximately 6 to 9 months.
- 4Import Tariff/Duty: Pharmaceuticals may be subject to import duties; current rates should be verified with Sri Lanka Customs.
Sri Lanka:
- 1Regulatory Authority: Medicines and Healthcare products Regulatory Agency (MHRA).
- 2Import Registration Process: Importers must hold a Wholesale Dealer's License and ensure the product has a Marketing Authorization.
- 3Estimated Timeline: The approval process can take 12 to 18 months.
- 4Import Tariff/Duty: Pharmaceuticals under HS Code 30049099 are generally duty-free; importers should confirm with UK Customs.
United Kingdom:
- 1Regulatory Authority: Instituto de Salud Pública de Chile (ISP).
- 2Import Registration Process: Importers must register the product with ISP, submitting detailed dossiers on quality, safety, and efficacy.
- 3Estimated Timeline: The registration process typically takes 12 to 24 months.
- 4Import Tariff/Duty: Pharmaceuticals may be subject to import duties; specific rates should be confirmed with Chilean Customs.
Chile:
Demand Drivers & Market Opportunity
TransData Nexus Leflunomide buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Leflunomide is primarily driven by the prevalence of autoimmune diseases such as rheumatoid arthritis. According to the World Health Organization (WHO), rheumatoid arthritis affects approximately 0.3–1% of the global population, with higher prevalence in developed countries. This underscores a consistent need for disease-modifying antirheumatic drugs (DMARDs) like Leflunomide.
Government healthcare programs and the expansion of universal health coverage significantly influence Leflunomide procurement. Many countries have incorporated Leflunomide into their national essential medicines lists, aligning with WHO recommendations to ensure accessibility to critical treatments. Additionally, international organizations such as the WHO and the Global Fund often facilitate tender-based purchasing, enhancing the availability of essential medicines in low- and middle-income countries. Our data, indicating 202 buyers across 63 countries, reflects a broad and sustained market opportunity for Leflunomide.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 202 global importers of Leflunomide identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 816 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 63 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
816 Verified Shipments
202 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists